title: Insomnia: chasing the dream.
authors.forename: James Mitchell
authors.initials: JM
authors.lastname: Crow
mesh_terms: D000818:Animals; D001143:Arousal / Q000187:drug effects / Q000502:physiology; D053961:Azabicyclo Compounds / Q000494:pharmacology / Q000627:therapeutic use; D001381:Azepines / Q000494:pharmacology / Q000627:therapeutic use; D001569:Benzodiazepines / Q000494:pharmacology / Q000627:therapeutic use; D015928:Cognitive Behavioral Therapy; D004316:Doxepin / Q000494:pharmacology / Q000627:therapeutic use; D004325:Dreams / Q000502:physiology; D017442:Histamine Agonists / Q000494:pharmacology / Q000627:therapeutic use; D006633:Histamine Antagonists / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D006993:Hypnotics and Sedatives / Q000494:pharmacology / Q000627:therapeutic use; D007031:Hypothalamus / Q000187:drug effects / Q000378:metabolism; D064446:Orexin Receptors; D010879:Piperazines / Q000494:pharmacology / Q000627:therapeutic use; D010880:Piperidines / Q000494:pharmacology / Q000627:therapeutic use; D043562:Receptors, G-Protein-Coupled / Q000037:antagonists & inhibitors / Q000378:metabolism; D018079:Receptors, GABA / Q000378:metabolism; D018100:Receptors, Histamine H3 / Q000145:classification / Q000378:metabolism; D018013:Receptors, Neuropeptide / Q000037:antagonists & inhibitors / Q000378:metabolism; D007319:Sleep Initiation and Maintenance Disorders / Q000503:physiopathology* / Q000628:therapy*; D014230:Triazoles / Q000494:pharmacology / Q000627:therapeutic use
chemical_list: D053961:Azabicyclo Compounds; D001381:Azepines; C581638:DORA-22; D017442:Histamine Agonists; D006633:Histamine Antagonists; D006993:Hypnotics and Sedatives; D064446:Orexin Receptors; D010879:Piperazines; D010880:Piperidines; D043562:Receptors, G-Protein-Coupled; D018079:Receptors, GABA; D018100:Receptors, Histamine H3; D018013:Receptors, Neuropeptide; D014230:Triazoles; C515050:zopiclone; C551624:suvorexant; D001569:Benzodiazepines; D004316:Doxepin